Lineage-specific STAT5 target gene activation in hematopoietic progenitor cells predicts the FLT3(+)-mediated leukemic phenotype.
Leukemia
2016
30
8
1725-33
Cryopreservation in Closed Bag Systems as an Alternative to Clean Rooms for Preparations of Peripheral Blood Stem Cells.
Adv Exp Med Biol
2016
951
67-76
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group.
Leukemia
2016
30
11
2248-2250
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
Sci Transl Med
2016
8
339
339ra71
Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Circ Cardiovasc Imaging
2016
9
4
e004316
Advanced gastric cancer. Status quo of systemic therapy and influence on the quality of life
Onkologe
2016
22
6
406-412
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.
Eur J Cancer
2016
60
210-25
RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICs.
Oncotarget
2016
7
36
57483-57484
Survival control of malignant lymphocytes by anti-apoptotic MCL-1.
Leukemia
2016
30
11
2152-2159
First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
J Nucl Med
2016
57
5
741-6